Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

Periodontal Health and Treatment Outcomes in Students From Three Countries

16. November 2026 aktualisiert von: Esra İlkerli Şençağlı

Investigation of the Prevalence, Severity, and Treatment Response of Periodontal Diseases Among Student Groups From Different Countries

This study aims to investigate the prevalence and severity of periodontal diseases among university students from three different national backgrounds (Iranian, Sudanese, and Turkish) and to evaluate their response to periodontal treatment.

A total of 348 students will be included in the study, comprising 116 Iranian, 116 Sudanese, and 116 Turkish students. Periodontal health assessments will be performed, and all participants will receive periodontal treatment according to the study protocol.

The study will compare periodontal disease prevalence and severity among the three groups and evaluate changes in periodontal health following treatment.

Studienübersicht

Status

Rekrutierung

Bedingungen

Intervention / Behandlung

Detaillierte Beschreibung

This study investigates the prevalence and severity of periodontal diseases among university students from three different national backgrounds and evaluates their response to periodontal treatment.

A total of 348 university students will be included in the study, consisting of 116 students of Iranian origin, 116 students of Sudanese origin, and 116 students of Turkish origin.

At baseline, all participants will undergo a comprehensive periodontal examination to assess their periodontal health status. Clinical periodontal parameters will be recorded using standardized periodontal assessment methods.

All participants will receive periodontal treatment according to the study protocol. The treatment includes professional scaling and oral hygiene instruction. Root planing will be performed when clinically indicated, depending on the periodontal condition of each participant.

Three weeks after treatment, participants will undergo a follow-up periodontal examination. Clinical periodontal parameters will be reassessed to evaluate changes in periodontal health and treatment response.

The findings will be compared among the three student groups to investigate differences in periodontal disease prevalence, severity, and response to treatment.

The study aims to provide information about periodontal health differences among students from different national backgrounds and their response to periodontal treatment.

Studientyp

Interventionell

Einschreibung (Geschätzt)

348

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienkontakt

Studienorte

      • Mórfou, Zypern
        • Rekrutierung
        • Cyprus Health and Social Sciences University
        • Kontakt:

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Being 18 years of age or older.
  • Having been born and raised in a country different from the country of current study.
  • Currently being enrolled as a student at Cyprus Health and Social Sciences University.
  • Having received no periodontal treatment within the previous six months.
  • Having at least 20 natural teeth.
  • Voluntarily agreeing to participate in the study and providing written informed consent.

Exclusion Criteria:

  • Completely edentulous individuals.
  • Individuals who have used systemic antibiotics or anti-inflammatory medications within the previous six months.
  • Individuals with a history of periodontal surgery.
  • Pregnant or breastfeeding individuals.
  • Individuals with immunosuppression due to systemic diseases or medical conditions (e.g., chemotherapy or HIV).

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Behandlung
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Periodontal Treatment Group

All 348 participants will receive periodontal treatment according to their individual clinical needs. Treatment will include scaling and root planing when clinically indicated. Participants will be evaluated at baseline and reassessed three weeks after treatment to assess periodontal treatment outcomes.

Participants will receive non-surgical periodontal treatment according to their individual clinical needs. The treatment will include scaling and root planing where clinically indicated. The procedure will be performed based on baseline periodontal examination findings. All participants will be reassessed three weeks after treatment to evaluate changes in periodontal clinical parameters, including plaque index, gingival index, probing pocket depth, clinical attachment level, and tooth mobility.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Probing Pocket Depth (PPD)
Zeitfenster: Baseline and 3 weeks after periodontal treatment

Change in mean probing pocket depth (PPD) from baseline to the three-week follow-up after periodontal treatment. Measurements will be compared among Iranian, Sudanese, and Turkish student groups.

Baseline and 3 weeks after periodontal treatment

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Change in Plaque Index (PI) Assessed Using the Silness and Löe Plaque Index
Zeitfenster: Baseline and 3 weeks

Dental plaque will be assessed clinically using the Silness and Löe Plaque Index (1964). Plaque accumulation will be scored on a scale ranging from 0 to 3:

0: No plaque.

  1. A film of plaque adhering to the free gingival margin and adjacent tooth area, detectable only by running a probe across the tooth surface.
  2. Moderate accumulation of soft deposits within the gingival pocket or on the tooth and gingival margin, visible to the naked eye.
  3. Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

The minimum score is 0 and the maximum score is 3. Higher scores indicate greater plaque accumulation and a worse oral hygiene outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Gingival Index (GI) Assessed Using the Löe and Silness Gingival Index
Zeitfenster: Baseline and 3 weeks

Gingival inflammation will be assessed clinically using the Löe and Silness Gingival Index (1963). Gingival tissues will be scored on a scale ranging from 0 to 3:

0: Normal gingiva, no inflammation.

  1. Mild inflammation, slight color change and slight edema, with no bleeding on probing.
  2. Moderate inflammation, redness, edema, and glazing, with bleeding on probing.
  3. Severe inflammation, marked redness and edema, ulceration, and a tendency to spontaneous bleeding.

The minimum score is 0 and the maximum score is 3. Higher scores indicate more severe gingival inflammation and a worse periodontal outcome. Measurements will be performed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Clinical Attachment Level (CAL)
Zeitfenster: Baseline and 3 weeks
Baseline and 3 weeks
Change in Tooth Mobility Assessed Using the Miller Mobility Index
Zeitfenster: Baseline and 3 weeks

Tooth mobility will be assessed clinically using the Miller Mobility Index. Each examined tooth will be evaluated for horizontal and vertical mobility using two rigid instrument handles. Mobility will be classified as follows:

Grade 0: Physiologic tooth mobility. Grade 1: Slight horizontal mobility of less than 1 mm. Grade 2: Horizontal mobility of more than 1 mm without vertical mobility. Grade 3: Severe horizontal mobility accompanied by vertical mobility.

Higher grades indicate greater tooth mobility and a worse periodontal outcome. Tooth mobility will be assessed at baseline and 3 weeks after periodontal treatment.

Baseline and 3 weeks
Change in Bleeding on Probing (BOP) Percentage
Zeitfenster: Baseline and 3 weeks

Bleeding on probing (BOP) will be assessed as a clinical indicator of gingival inflammation using a periodontal probe. The periodontal probe will be gently inserted into the gingival sulcus to evaluate the presence or absence of bleeding following probing.

Each periodontal site will be recorded using a dichotomous scoring system:

Score 0: Absence of bleeding on probing. Score 1: Presence of bleeding on probing.

The BOP percentage will be calculated by dividing the total number of bleeding-positive sites by the total number of examined periodontal sites and multiplying by 100.

BOP (%) = (Number of bleeding-positive sites / Total number of examined sites) × 100.

The minimum value is 0% and the maximum value is 100%. Higher percentages indicate a greater proportion of bleeding sites and more pronounced gingival inflammation.

Baseline and 3 weeks
Prevalence and Severity of Periodontal Disease
Zeitfenster: Baseline
Baseline

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Sponsor

Ermittler

  • Studienstuhl: Halil İbrahim Taşer, Prof.Dr., Cyprus Health and Social Sciences University
  • Hauptermittler: Esra İlkerli Şençağlı, Dt., Cyprus Health and Social Sciences University

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

6. Mai 2026

Primärer Abschluss (Geschätzt)

6. Mai 2029

Studienabschluss (Geschätzt)

6. Mai 2029

Studienanmeldedaten

Zuerst eingereicht

6. November 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

16. November 2026

Zuerst gepostet (Tatsächlich)

18. November 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

18. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

16. November 2026

Zuletzt verifiziert

1. November 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • ESRA-PERIO-001

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

NEIN

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .